Overview

Safety/Feasibility of Vonapanitase Following Angioplasty for Patients With Peripheral Artery Disease (PAD) Below the Knee (BTK)

Status:
Completed
Trial end date:
2019-04-30
Target enrollment:
Participant gender:
Summary
The research study is designed to assess the technical feasibility and safety of a perivascular injection of vonapanitase delivered via micro-infusion catheter to the distal popliteal, tibial or peroneal arteries immediately following successful angioplasty.
Phase:
Phase 1
Details
Lead Sponsor:
Proteon Therapeutics